Pacira BioSciences
PCRX
PCRX
187 hedge funds and large institutions have $3.03B invested in Pacira BioSciences in 2015 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 73 increasing their positions, 63 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $3.58B → $3.03B (-$553M)
34% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 47
Holders
187
Holding in Top 10
4
Calls
$31.6M
Puts
$24.3M
Top Buyers
| 1 | +$111M | |
| 2 | +$89.3M | |
| 3 | +$54.2M | |
| 4 |
Goldman Sachs
New York
|
+$52.8M |
| 5 |
VAM
Visium Asset Management
New York
|
+$43.5M |
Top Sellers
| 1 | -$83M | |
| 2 | -$54.3M | |
| 3 | -$31.9M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$29.5M |
| 5 |
HCM
Hodges Capital Management
Dallas,
Texas
|
-$26.2M |